***Background.*** CDC recommends an antibiotic time out after culture results become available. We devised a self-directed time out program to guide providers to (re)consider the continuation of antibiotics past day 3.

***Methods.*** We implemented the time out program at a teaching hospital where continuation of vancomycin (VAN) and piperacillin-tazobactam (P-T) past day 3 previously required Infectious Diseases approval. We created an electronic antibiotic renewal template that included a structured review of antibiotic indications with links to local guidelines that provided automatic approval upon completion. Providers were notified of time out on day 4 via an electronic dashboard that summarized the patient\'s microbiological and clinical status. We assessed template utilization in the first 6 months of implementation (April to October 2013) among providers who received time out notification and determined via expert chart review whether self-continuation of VAN or P-T through day 5 was discordant with local guidelines as compared to a six-month period 1 year prior (April to October 2012).

***Results.*** Of 145 VAN time outs, templates were completed in 55 (38%); of these, VAN was continued through day 5 in 39. VAN was allowed to expire without template completion in 77 (53%). VAN was active through day 5 despite no template in 13 (9%). 7 continuations of VAN via template (5% of timeouts) were guideline-discordant, as compared to 0/199 1y prior (p = 0.002). Overall, VAN discontinuation was higher with the time out program as compared to 1y prior: 93/145 (64%) vs 96/199 (48%), p = 0.004.

Of 105 P-T time outs, templates were completed in 52 (49.5%); of these, P-T was continued through day 5 in 33. P-T was allowed to expire without template completion in 51 (48.5%). P-T was active through day 5 despite no template in 2 (2%). 9 continuations of P-T (9% of time outs) via template were guideline-discordant, as compared to 2/93 (2%) 1y prior (p = 0.063). Overall, P-T discontinuation was similar with the time out program as compared to 1 year prior: 70/105 (67%) vs 58/93 (62%), p = 0.55.

***Conclusion.*** The self-directed time out resulted in few guideline-discordant continuations and a higher overall rate of VAN discontinuation, suggesting that the time out prompted providers to discontinue VAN in cases where they previously might have sought Infectious Diseases approval for continuation.
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